Healthcare dealmakers gathering in San Francisco for the industry’s premier annual conference this week say they expect a resurgence of deals exceeding $10 billion due to the potential for less antitrust scrutiny under President-elect Donald Trump. Seventeen healthcare dealmakers who spoke with Reuters were unanimously optimistic about a M&A recovery after last year seeing no transactions above $5 billion close in the sector for the first time in at least a decade. Following Trump’s election to a second term in November, deals that had been shelved due to antitrust risk, high interest rates, or the decline in share values after the COVID-19 pandemic were getting a second look, bankers and lawyers said.
Read the full article: Healthcare Dealmakers Eye M&A Resurgence in Second Trump Term //
Source: https://www.msn.com/en-ca/money/topstories/healthcare-dealmakers-eye-m-a-resurgence-in-second-trump-term/ar-BB1rmE5w